{
  "table_name": "TESTIS_RETRO_LYMPH",
  "description": "Stores data for College of American Pathologists (CAP) form 76054-TESTIS: Retroperitoneal Lymphadenectomy.",
  "primary_key": {
    "column_name": "RESULT_ID",
    "ordinal_position": "1"
  },
  "columns": [
    {
      "index": 2,
      "name": "RESULT_ID",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "The unique identifier for the result record."
    },
    {
      "index": 7,
      "name": "CAP_COMMENTS",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: General comments."
    },
    {
      "index": 12,
      "name": "SPECIMEN_OTHER_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify other specimen."
    },
    {
      "index": 17,
      "name": "REGIONL_LYMPH_ND_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes (pN).\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\npNX: Cannot be assessed\n\n\npN0: No regional lymph node metastasis\n\n\npN1: Regional lymph node metastasis\n\n\npN1: Metastasis in perirectal lymph nodes\n\n\npN1: Metastasis in 1 to 3 regional lymph nodes\n\n\npN1a: Metastasis in 1 regional lymph node\n\n\npN1b: Metastasis in 2 to 3 regional lymph nodes\n\n\npN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta\n\n\npN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes\n\n\npN1: Regional lymph node metastasis involving 1 to 2 nodes\n\n\npN1 (IIIC): Regional lymph node metastasis\n\n\npN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery\n\n\npN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension\n\n\npN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, \n\n\npN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes\n\n\npN1a: Clinically occult (microscopic) metastasis\n\n\npN1b: Clinically apparent (macroscopic) metastasis\n\n\npN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension\n\n\npN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension\n\n\npN1: Metastasis in 1 to 2 perigastric lymph nodes\n\n\npN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,\n\n\npN1a: Nodal metastases to Level VI lymph nodes\n\n\npN1b: Metastases to unilateral, bilateral or contralateral cervical \n\n\npN1: Single regional lymph node metastasis in the true pelvis \n\n\npN1 (IVB): Pelvic or inguinal lymph node metastasis\n\n\npN1: Metastasis in regional lymph node or nodes\n\n\npN1: Regional lymph node involvement (preauricular, cervical, submandibular)\n\n\npN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)\n\n\npN2: Metastasis in 4 or more regional lymph nodes\n\n\npN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd\n\n\npN2a: Metastasis in 4 to 6 regional lymph nodes\n\n\npN2b: Metastasis in 7 or more regional lymph nodes\n\n\npN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho\n\n\npN2: 3 to 6 nodes involved\n\n\npN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n\n\n\npN2: Metastasis in a single ipsilateral lymph node, more than 3 cm\n\n\npN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than\n\n\npN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension\n\n\npN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension\n\n\npN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.\n\n\npN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)\n\n\npN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes \n\n\npN2a: Clinically occult (microscopic) metastasis\n\n\npN2b: Clinically apparent (macroscopic) metastasis\n\n\npN2c: Satellite or in-transit metastasis without nodal metastasis\n\n\npN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension\n\n\npN2: Metastasis in a single regional lymph node, more than 2 cm but not more than\n\n\npN2: Metastasis in 3 to 6 perigastric lymph nodes\n\n\npN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm \n\n\npN2: Multiple regional lymph node metastasis in the true pelvis \n\n\npN2: Distant lymph node involvement\n\n\npN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il\n\n\npN3: 7 or more nodes involved\n\n\npN3: Metastasis in a lymph node more than 6 cm in greatest dimension\n\n\npN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or\n\n\npN3: Metastases in the contralateral mediastinal, contralateral internal mammary,\n\n\npN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or\n\n\npN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa\n\n\npN3a: Greater than 6 cm in dimension\n\n\npN3b: Extension to the supraclavicular fossa\n\n\npN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension\n\n\npN3: Metastasis in 7 or more perigastric lymph nodes\n\n\npN3a: Metastasis in 7 to 15 perigastric lymph nodes\n\n\npN3b: Metastasis in 16 or more perigastric lymph nodes\n\n\npN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension\n\n\npN3: Lymph node metastasis to the common iliac lymph nodes\n\n\npN1: One or two regional lymph nodes with the following features\n\n\npN2 (FIGO IIIB): Regional lymph node metastasis with the following features\n\n\npN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis"
    },
    {
      "index": 93,
      "name": "REG_LN_NUM_EXM",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes Number Examined."
    },
    {
      "index": 98,
      "name": "REG_LN_NUM_INV",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes Number Involved."
    },
    {
      "index": 103,
      "name": "HIS_TYP_GERM_COMPS",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Histologic Type - Specify Mixed Germ Cell Tumor Components and Approximate Percentages."
    },
    {
      "index": 108,
      "name": "HIST_TYPE_TERATOMA",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Histologic Type - Specify Teratoma with a Secondary Somatic-type Malignant Component."
    },
    {
      "index": 113,
      "name": "HIST_TYP_MONOD_OTH",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Histologic Type - Specify Monodermal Teratoma Other."
    },
    {
      "index": 118,
      "name": "HIST_TP_SQUA_CCNM_S",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify details for Histologic Type Squamous cell carcinoma."
    },
    {
      "index": 123,
      "name": "SZ_LRGST_METAS_DEP",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Size of Largest Metastatic Deposit."
    },
    {
      "index": 128,
      "name": "PRELYMPH_TREATMNT_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Prelymphadenectomy Treatment.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nChemo / radiation therapy\n\n\nNo chemo / radiation therapy\n\n\nUnknown"
    },
    {
      "index": 138,
      "name": "NUM_NODAL_GROUPS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Number of Nodal Groups Present.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nSpecify\n\n\nCannot be determined"
    },
    {
      "index": 147,
      "name": "NUM_NOD_GRP_PRESENT",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify the Number of Nodal Groups Present."
    },
    {
      "index": 152,
      "name": "SIZE_META_DEP_ADD_1",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Size of Largest Metastatic Deposit (additional measurement 1)."
    },
    {
      "index": 157,
      "name": "SIZE_META_DEP_ADD_2",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Size of Largest Metastatic Deposit (additional measurement 2)."
    },
    {
      "index": 162,
      "name": "HIST_VIABILITY_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Histologic Viability of Tumor.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nViable teratoma present\n\n\nViable non-teratomatous tumor present\n\n\nNo viable tumor present\n\n\nNot applicable"
    },
    {
      "index": 173,
      "name": "NON_REG_LYM_META_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Nonregional Lymph Node Metastasis.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nNot applicable\n\n\nNot identified\n\n\nPresent"
    }
  ]
}
